International Clinical Trial: A prospective, multicenter, randomized, open-label, parallel-controlled clinical study on the combination of toripalimab with PD-1 inhibitors in neoadjuvant chemoradiotherapy for locally advanced pMMR/MSS rectal cancer

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131840) titled 'A prospective, multicenter, randomized, open-label, parallel-controlled clinical study on the combination of toripalimab with PD-1 inhibitors in neoadjuvant chemoradiotherapy for locally advanced pMMR/MSS rectal cancer' on Sept. 7.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)

Condition: pMMR/MSS locally advanced rectal cancer

Intervention: Experimental group:Neoadjuvant chemoradiotherapy combined with PD-1 immunotherapy and tafolecimab

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enr...